SMTI: Sanara P/S Multiple

Corporate company logo of Sanara (SMTI)

The market cap-to-revenue ratio on the GURU.Markets chart highlights Sanara MedTech Inc. (SMTI) as a leader in tissue regeneration trusted by surgeons. The current value of 2.70 reflects the asset's dynamics, supported by a strong team of biomaterials scientists in R&D. Meanwhile, financial success relies on government procurement and the expansion of distribution for specialized skin healing products.

SMTI (sanaramedtech.com) P/S Multiple history from 07/04/2022 to 11/14/2026

Analytical breakdowns for Sanara MedTech Inc. (SMTI)

- price and consensus price forecast:
Market Chart sanaramedtech.com|SMTI - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Sanara|SMTI - Total Company Value
- balance sheet equity data:
Equity per Share Sanara MedTech|SMTI - Book Capitalization|Market Capitalization to Book Value Ratio sanaramedtech.com|SMTI - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Sanara MedTech Inc.|SMTI - Long-Term Debt to Capital|Short-Term Debt to Capital sanaramedtech.com|SMTI - Company Total Debt|Debt to Net Assets Ratio Sanara|SMTI - Company Long-Term Debt|Company Current Liabilities Sanara MedTech|Immediate Liquidity sanaramedtech.com
- net income and valuation multiples indicators:
SMTI - Net Profit|Net Profit Forecast Sanara MedTech Inc.|SMTI - Price to Earnings Ratio|Market Cap to Future Earnings Ratio sanaramedtech.com|SMTI - PEG Multiple|Company Value to EBITDA Sanara|SMTI - Operating profit EBITDA|Net earnings per share for the last 12 months Sanara MedTech|SMTI - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months sanaramedtech.com|SMTI - Net earnings per share growth this year|Expected earnings per share trend next year Sanara MedTech Inc.
- issuer revenue and sales details:
SMTI - Revenue and Sales Volume|Company Future Sales sanaramedtech.com|SMTI - Price-to-Revenue Ratio|Market Cap to Projected Revenue Sanara
Summary company analytics:Sanara MedTech, Inc., SMTI
Finished products of Sanara MedTech Inc.

The warehouse logistics efficiency and energy-saving costs of Sanara MedTech Inc. (SMTI) are reflected in the price-to-sales trend on the GURU.Markets platform. This ratio, which divides market capitalization by annual sales volume, measures the premium for future growth, where low values signal high asset resilience to shocks and provide fundamental protection for investor capital.

Competitors of Sanara MedTech Inc.

Price-to-Revenue Coefficient krystalbio.com|P/S Multiple APGE (Apogee Therapeutics, Inc.)|P/S Multiple Arcutis ARQT|VCEL - Price-to-Revenue Ratio|ORKA (Oruka Pharma) - Market Cap to Revenue Ratio|DBVT: P/S Multiple|Solesence (SLSN) - P/S Multiple|Price-to-Revenue Ratio Journey Medical Corp|FBRX: Market Capitalization-to-Revenue Ratio|P/S Multiple EMPG|P/S Multiple Sol-Gel Technologies, Ltd. (SLGL)|AXIL Brands - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio MDCX|VRCA - Price-to-Revenue Ratio|Hoth Therapeutics, Inc. (HOTH) - Market Cap to Revenue|BFRI: P/S Multiple|Price to Sales VYNE Therapeutics Inc. (VYNE)|SNOA (Sonoma Pharmaceuticals Inc.) - P/S Multiple|Market Cap to Revenue Ratio QNRX (Quoin Pharma)|Market Cap to Revenue AZTR (Azitra)|Market Cap to Sales Volume DRMA|P/S Multiple ELAB (Elevai Skincare)|Revance Therapeutics Inc (RVNC) - Price to Sales